BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8227822)

  • 1. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.
    Pflugfelder PW; Baird MG; Tonkon MJ; DiBianco R; Pitt B
    J Am Coll Cardiol; 1993 Nov; 22(6):1557-63. PubMed ID: 8227822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure.
    Riegger GA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S41-6. PubMed ID: 1691406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
    Northridge DB; Rose E; Raftery ED; Lahiri A; Elder AT; Shaw TR; Henderson E; Dargie HJ
    Eur Heart J; 1993 Mar; 14(3):403-9. PubMed ID: 8458362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinapril in patients with congestive heart failure: controlled trial versus captopril.
    Acanfora D; Furgi G; Trojano L; Picone C; Iannuzzi GL; Rossi M; Papa A; Rengo C; Rengo F
    Am J Ther; 1997; 4(5-6):181-8. PubMed ID: 10423609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
    Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
    Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL; Sorkin EM
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinapril hydrochloride effects on renal function in patients with renal dysfunction and hypertension: a drug-withdrawal study.
    Miller MA; Texter M; Gmerek A; Robbins J; Shurzinske L; Canter D
    Cardiovasc Drugs Ther; 1994 Apr; 8(2):271-5. PubMed ID: 7918140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm.
    Kromer EP; Elsner D; Riegger GA
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):9-14. PubMed ID: 1696671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure.
    Riegger GA
    Eur Heart J; 1991 Jun; 12(6):705-11. PubMed ID: 1830551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative trial of quinapril versus captopril in mild to moderate congestive heart failure. Quinapril/Captopril Congestive Heart Failure Study Group.
    Gavazzi A; Marioni R; Campana C; Montemartini C
    J Hypertens Suppl; 1994 Jul; 12(4):S89-93. PubMed ID: 7965279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety profile of quinapril: is there a difference among ACE inhibitors?
    Canter D; Frank GJ; Knapp LE; McLain RW
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII39-42. PubMed ID: 2189620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hemodynamics effects of ACE inhibitors in the treatment of congestive heart failure.
    Nieminen MS; Kupari M
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S36-40. PubMed ID: 1691405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
    Nussberger J; Fleck E; Bahrmann H; Delius W; Schultheiss HP; Brunner HR
    Eur Heart J; 1994 Dec; 15 Suppl D():113-22. PubMed ID: 7713100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of quinapril on functional status of elderly patients with diastolic heart failure.
    Zi M; Carmichael N; Lye M
    Cardiovasc Drugs Ther; 2003 Mar; 17(2):133-9. PubMed ID: 12975595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinapril in chronic heart failure.
    Northridge DB; Dargie HJ
    Am J Hypertens; 1990 Nov; 3(11):283S-287S. PubMed ID: 2261147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of quinapril, a new ACE inhibitor.
    Frank GJ; Knapp LE; Olson SC; Phelps MC; Quade MM; Rieger MM; Sedman AJ
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S14-23. PubMed ID: 1691402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
    Culy CR; Jarvis B
    Drugs; 2002; 62(2):339-85. PubMed ID: 11817979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall tolerance and safety of quinapril in clinical trials.
    Frank GJ; Knapp LE; McLain RW
    Angiology; 1989 Apr; 40(4 Pt 2):405-15. PubMed ID: 2650583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary hemodynamic report of the efficacy and safety of quinapril in acute and chronic treatment of patients with congestive heart failure.
    Banas JS
    Angiology; 1989 Apr; 40(4 Pt 2):396-404. PubMed ID: 2705644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.